Janssen UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K Premium Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences. Microbes Behind Successful Fecal Microbiota Transplantations May Become Basis for New Treatments With microbial sequencing data for FMT donors and recipients, researchers defined which bugs take up long-term residence in recipient guts. Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement Persephone is developing precision immunotherapeutics using microbiome and other medical data from healthy individuals and cancer patients. FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC The agency approved amivantamab for non-small cell lung cancer patients harboring EGFR exon 20 mutations, as detected by Guardant Health's blood-based test. Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials. Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Dec 7, 2020 UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Nov 2, 2020 Tempus, Janssen R&D Collaborate on Oncology Clinical Trial Matching Sep 29, 2020 Sema4, Janssen Partner on Patient Identification for Cancer Clinical Trials Aug 12, 2020 GeneCentric Therapeutics, Janssen Partner to Uncover Bladder Cancer Biomarkers Jul 22, 2020 Alzheimer's Drug Discovery Foundation, Pharma Firms Form Biobank Alliance Jul 8, 2020 Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy Apr 10, 2020 Free Bioinformatics Tool From Nference, Janssen Uncovers New COVID-19 Insights Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Aug 28, 2019 HIV, SIV Protection Associated With Post-Vaccination Gene Expression Signature Jul 9, 2019 Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance Jun 19, 2019 Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer Apr 26, 2019 European Project Aims to Develop Tools, Guidelines to Improve Data Sharing, Access Premium Apr 12, 2019 FDA Approves Qiagen Companion Dx for Bladder Cancer Drug Balversa Apr 9, 2019 Somalogic Collaborating With Janssen on Protein Biomarker Research Dec 12, 2018 BiomX Inks IBD Biomarker Deal With Janssen Nov 26, 2018 Proteomics International, Janssen Collaborating to Evaluate PromarkerD Kidney Disease Test Jun 14, 2018 Janssen Plans Year-End Erdafitinib Filing Based on Phase II Data in FGFR-Mutated Bladder Cancer Premium May 8, 2018 GenomeDx, Janssen Partner to Test Tumor Genome Profile Database Load More Breaking News Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation Lifespan Linked to Lower Protein Synthesis Gene Expression Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.